nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—rheumatoid arthritis	0.779	1	CiPCiCtD
Cytarabine—ABCC10—Cyclosporine—rheumatoid arthritis	0.0758	0.461	CbGbCtD
Cytarabine—ABCC10—Methotrexate—rheumatoid arthritis	0.0401	0.244	CbGbCtD
Cytarabine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00999	0.0608	CbGbCtD
Cytarabine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00737	0.0448	CbGbCtD
Cytarabine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00558	0.034	CbGbCtD
Cytarabine—CYP3A4—Betamethasone—rheumatoid arthritis	0.00479	0.0291	CbGbCtD
Cytarabine—CYP3A4—Prednisolone—rheumatoid arthritis	0.00473	0.0288	CbGbCtD
Cytarabine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00448	0.0273	CbGbCtD
Cytarabine—CYP3A4—Prednisone—rheumatoid arthritis	0.00446	0.0272	CbGbCtD
Cytarabine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00423	0.0257	CbGbCtD
Cytarabine—NT5E—cartilage tissue—rheumatoid arthritis	0.00422	0.127	CbGeAlD
Cytarabine—POLD1—exocrine gland—rheumatoid arthritis	0.003	0.0904	CbGeAlD
Cytarabine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00279	0.017	CbGbCtD
Cytarabine—DCTD—parotid gland—rheumatoid arthritis	0.00154	0.0465	CbGeAlD
Cytarabine—POLD1—saliva-secreting gland—rheumatoid arthritis	0.0015	0.0451	CbGeAlD
Cytarabine—DCTD—saliva-secreting gland—rheumatoid arthritis	0.00148	0.0445	CbGeAlD
Cytarabine—POLB—lymphoid tissue—rheumatoid arthritis	0.00123	0.0371	CbGeAlD
Cytarabine—POLE—saliva-secreting gland—rheumatoid arthritis	0.00112	0.0337	CbGeAlD
Cytarabine—NT5E—connective tissue—rheumatoid arthritis	0.00105	0.0316	CbGeAlD
Cytarabine—POLA1—parotid gland—rheumatoid arthritis	0.00101	0.0303	CbGeAlD
Cytarabine—POLD1—lymphoid tissue—rheumatoid arthritis	0.00101	0.0303	CbGeAlD
Cytarabine—POLD1—digestive system—rheumatoid arthritis	0.000994	0.0299	CbGeAlD
Cytarabine—DCTD—digestive system—rheumatoid arthritis	0.000981	0.0295	CbGeAlD
Cytarabine—DCTD—tendon—rheumatoid arthritis	0.000933	0.0281	CbGeAlD
Cytarabine—CDA—lymphoid tissue—rheumatoid arthritis	0.000903	0.0272	CbGeAlD
Cytarabine—CDA—tendon—rheumatoid arthritis	0.000849	0.0256	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—rheumatoid arthritis	0.000768	0.0231	CbGeAlD
Cytarabine—POLE—lymphoid tissue—rheumatoid arthritis	0.000753	0.0227	CbGeAlD
Cytarabine—POLE—digestive system—rheumatoid arthritis	0.000743	0.0224	CbGeAlD
Cytarabine—NT5E—tendon—rheumatoid arthritis	0.000722	0.0217	CbGeAlD
Cytarabine—POLE—tendon—rheumatoid arthritis	0.000707	0.0213	CbGeAlD
Cytarabine—Glucosamine—IFNG—rheumatoid arthritis	0.000668	0.26	CrCbGaD
Cytarabine—Vidarabine—DPP4—rheumatoid arthritis	0.000664	0.258	CrCbGaD
Cytarabine—DCK—parotid gland—rheumatoid arthritis	0.000621	0.0187	CbGeAlD
Cytarabine—POLA1—tendon—rheumatoid arthritis	0.00061	0.0184	CbGeAlD
Cytarabine—DCK—saliva-secreting gland—rheumatoid arthritis	0.000595	0.0179	CbGeAlD
Cytarabine—ABCC10—parotid gland—rheumatoid arthritis	0.000592	0.0178	CbGeAlD
Cytarabine—SLC29A1—connective tissue—rheumatoid arthritis	0.000572	0.0172	CbGeAlD
Cytarabine—ABCC10—saliva-secreting gland—rheumatoid arthritis	0.000567	0.0171	CbGeAlD
Cytarabine—Adenosine—DPP4—rheumatoid arthritis	0.000531	0.207	CrCbGaD
Cytarabine—SLC22A2—digestive system—rheumatoid arthritis	0.000477	0.0144	CbGeAlD
Cytarabine—Glucosamine—MMP9—rheumatoid arthritis	0.000426	0.166	CrCbGaD
Cytarabine—SLC29A1—lymphoid tissue—rheumatoid arthritis	0.000419	0.0126	CbGeAlD
Cytarabine—SLC29A1—digestive system—rheumatoid arthritis	0.000413	0.0124	CbGeAlD
Cytarabine—DCK—lymphoid tissue—rheumatoid arthritis	0.0004	0.012	CbGeAlD
Cytarabine—DCK—digestive system—rheumatoid arthritis	0.000395	0.0119	CbGeAlD
Cytarabine—SLC29A1—tendon—rheumatoid arthritis	0.000393	0.0118	CbGeAlD
Cytarabine—ABCC10—lymphoid tissue—rheumatoid arthritis	0.000381	0.0115	CbGeAlD
Cytarabine—ABCC10—digestive system—rheumatoid arthritis	0.000376	0.0113	CbGeAlD
Cytarabine—DCK—tendon—rheumatoid arthritis	0.000376	0.0113	CbGeAlD
Cytarabine—ABCC10—tendon—rheumatoid arthritis	0.000358	0.0108	CbGeAlD
Cytarabine—Glucosamine—TNF—rheumatoid arthritis	0.00028	0.109	CrCbGaD
Cytarabine—POLD1—Danazol—Hydrocortisone—rheumatoid arthritis	0.000278	0.139	CbGdCrCtD
Cytarabine—POLD1—Danazol—Prednisone—rheumatoid arthritis	0.00024	0.119	CbGdCrCtD
Cytarabine—POLA1—Norethindrone—Hydrocortisone—rheumatoid arthritis	0.000172	0.0856	CbGdCrCtD
Cytarabine—CYP3A4—digestive system—rheumatoid arthritis	0.000154	0.00462	CbGeAlD
Cytarabine—POLA1—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000137	0.0681	CbGdCrCtD
Cytarabine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—rheumatoid arthritis	0.000102	0.00525	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDK5RAP2—rheumatoid arthritis	0.0001	0.00516	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CEP57—rheumatoid arthritis	0.0001	0.00516	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—SLC25A12—rheumatoid arthritis	0.0001	0.00516	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—HMGB1—rheumatoid arthritis	9.87e-05	0.00508	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGES—rheumatoid arthritis	9.76e-05	0.00502	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GC—rheumatoid arthritis	9.76e-05	0.00502	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—IL6—rheumatoid arthritis	9.72e-05	0.005	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDK5RAP2—rheumatoid arthritis	9.69e-05	0.00499	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CEP57—rheumatoid arthritis	9.69e-05	0.00499	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Hydrocortisone—rheumatoid arthritis	9.64e-05	0.048	CbGdCrCtD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	9.56e-05	0.00492	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—FADS2—rheumatoid arthritis	9.51e-05	0.00489	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	9.3e-05	0.00478	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Methylprednisolone—rheumatoid arthritis	9.1e-05	0.0453	CbGdCrCtD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—rheumatoid arthritis	9.09e-05	0.00468	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PLB1—rheumatoid arthritis	9.07e-05	0.00467	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Betamethasone—rheumatoid arthritis	8.95e-05	0.0446	CbGdCrCtD
Cytarabine—DCK—Desoximetasone—Dexamethasone—rheumatoid arthritis	8.95e-05	0.0446	CbGdCrCtD
Cytarabine—DCK—Diflorasone—Methylprednisolone—rheumatoid arthritis	8.83e-05	0.044	CbGdCrCtD
Cytarabine—DCK—Desoximetasone—Triamcinolone—rheumatoid arthritis	8.75e-05	0.0436	CbGdCrCtD
Cytarabine—CDA—Metabolism—FADS2—rheumatoid arthritis	8.7e-05	0.00447	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Dexamethasone—rheumatoid arthritis	8.69e-05	0.0433	CbGdCrCtD
Cytarabine—DCK—Diflorasone—Betamethasone—rheumatoid arthritis	8.69e-05	0.0433	CbGdCrCtD
Cytarabine—POLD1—Cell Cycle, Mitotic—RAB8A—rheumatoid arthritis	8.51e-05	0.00438	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Triamcinolone—rheumatoid arthritis	8.49e-05	0.0423	CbGdCrCtD
Cytarabine—DCK—Desoximetasone—Prednisone—rheumatoid arthritis	8.3e-05	0.0414	CbGdCrCtD
Cytarabine—POLE—Cell Cycle, Mitotic—RAB8A—rheumatoid arthritis	8.22e-05	0.00423	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Prednisolone—rheumatoid arthritis	8.1e-05	0.0404	CbGdCrCtD
Cytarabine—DCK—Diflorasone—Prednisone—rheumatoid arthritis	8.06e-05	0.0402	CbGdCrCtD
Cytarabine—DCTD—Metabolism—MED1—rheumatoid arthritis	7.95e-05	0.00409	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Prednisolone—rheumatoid arthritis	7.86e-05	0.0392	CbGdCrCtD
Cytarabine—ABCC10—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	7.8e-05	0.00401	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CEP57—rheumatoid arthritis	7.72e-05	0.00397	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDK5RAP2—rheumatoid arthritis	7.72e-05	0.00397	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RAB8A—rheumatoid arthritis	7.61e-05	0.00391	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	7.58e-05	0.0039	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ACP5—rheumatoid arthritis	7.39e-05	0.0038	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—B3GNT2—rheumatoid arthritis	7.39e-05	0.0038	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDK6—rheumatoid arthritis	7.39e-05	0.0038	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RAB8A—rheumatoid arthritis	7.35e-05	0.00378	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—TMPO—rheumatoid arthritis	6.95e-05	0.00357	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDK5RAP2—rheumatoid arthritis	6.91e-05	0.00355	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CEP57—rheumatoid arthritis	6.91e-05	0.00355	CbGpPWpGaD
Cytarabine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—rheumatoid arthritis	6.82e-05	0.00351	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—BGN—rheumatoid arthritis	6.66e-05	0.00343	CbGpPWpGaD
Cytarabine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—rheumatoid arthritis	6.35e-05	0.00327	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PLD4—rheumatoid arthritis	6.34e-05	0.00326	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	6.18e-05	0.00318	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ALOX5—rheumatoid arthritis	6.13e-05	0.00315	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ACAN—rheumatoid arthritis	6.13e-05	0.00315	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	5.96e-05	0.00306	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RAB8A—rheumatoid arthritis	5.85e-05	0.00301	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PLD4—rheumatoid arthritis	5.8e-05	0.00299	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SLC25A12—rheumatoid arthritis	5.76e-05	0.00296	CbGpPWpGaD
Cytarabine—DCK—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	5.64e-05	0.0281	CbGdCrCtD
Cytarabine—NT5E—Metabolism—GC—rheumatoid arthritis	5.6e-05	0.00288	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ACAN—rheumatoid arthritis	5.6e-05	0.00288	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGES—rheumatoid arthritis	5.6e-05	0.00288	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—FADS2—rheumatoid arthritis	5.39e-05	0.00278	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TMPO—rheumatoid arthritis	5.38e-05	0.00277	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	5.34e-05	0.00275	CbGpPWpGaD
Cytarabine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	5.31e-05	0.00273	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SLC25A12—rheumatoid arthritis	5.27e-05	0.00271	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RAB8A—rheumatoid arthritis	5.23e-05	0.00269	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PLB1—rheumatoid arthritis	5.21e-05	0.00268	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TMPO—rheumatoid arthritis	5.2e-05	0.00267	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GC—rheumatoid arthritis	5.12e-05	0.00264	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGES—rheumatoid arthritis	5.12e-05	0.00264	CbGpPWpGaD
Cytarabine—DCK—Metabolism—FADS2—rheumatoid arthritis	5.07e-05	0.00261	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—UBE2D1—rheumatoid arthritis	5e-05	0.00257	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ENO1—rheumatoid arthritis	4.99e-05	0.00257	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—rheumatoid arthritis	4.97e-05	0.00256	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—TMPO—rheumatoid arthritis	4.95e-05	0.00255	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	4.84e-05	0.00249	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TMPO—rheumatoid arthritis	4.81e-05	0.00248	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PLB1—rheumatoid arthritis	4.76e-05	0.00245	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	4.72e-05	0.00243	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TMPO—rheumatoid arthritis	4.65e-05	0.00239	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—rheumatoid arthritis	4.64e-05	0.00239	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MED1—rheumatoid arthritis	4.57e-05	0.00235	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—rheumatoid arthritis	4.4e-05	0.00227	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—B3GNT2—rheumatoid arthritis	4.25e-05	0.00219	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ACP5—rheumatoid arthritis	4.25e-05	0.00219	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MED1—rheumatoid arthritis	4.18e-05	0.00215	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDK6—rheumatoid arthritis	3.94e-05	0.00203	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ACP5—rheumatoid arthritis	3.88e-05	0.002	CbGpPWpGaD
Cytarabine—CDA—Metabolism—B3GNT2—rheumatoid arthritis	3.88e-05	0.002	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—UBE2D1—rheumatoid arthritis	3.87e-05	0.00199	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—BGN—rheumatoid arthritis	3.82e-05	0.00197	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	3.81e-05	0.00196	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDK6—rheumatoid arthritis	3.8e-05	0.00196	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—UBE2D1—rheumatoid arthritis	3.74e-05	0.00193	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TMPO—rheumatoid arthritis	3.7e-05	0.00191	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	3.67e-05	0.00189	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	3.65e-05	0.00188	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—rheumatoid arthritis	3.62e-05	0.00186	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PLD4—rheumatoid arthritis	3.6e-05	0.00185	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CAT—rheumatoid arthritis	3.59e-05	0.00185	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—UBE2D1—rheumatoid arthritis	3.56e-05	0.00183	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDK6—rheumatoid arthritis	3.52e-05	0.00181	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—rheumatoid arthritis	3.52e-05	0.00181	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ALOX5—rheumatoid arthritis	3.52e-05	0.00181	CbGpPWpGaD
Cytarabine—CDA—Metabolism—BGN—rheumatoid arthritis	3.5e-05	0.0018	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ACAN—rheumatoid arthritis	3.48e-05	0.00179	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—UBE2D1—rheumatoid arthritis	3.46e-05	0.00178	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDK6—rheumatoid arthritis	3.4e-05	0.00175	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	3.4e-05	0.00175	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PLD4—rheumatoid arthritis	3.38e-05	0.00174	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—BIRC5—rheumatoid arthritis	3.38e-05	0.00174	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	3.35e-05	0.00172	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—UBE2D1—rheumatoid arthritis	3.35e-05	0.00172	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TMPO—rheumatoid arthritis	3.31e-05	0.0017	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SLC25A12—rheumatoid arthritis	3.27e-05	0.00168	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ACAN—rheumatoid arthritis	3.27e-05	0.00168	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ALOX5—rheumatoid arthritis	3.22e-05	0.00166	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GC—rheumatoid arthritis	3.18e-05	0.00164	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGES—rheumatoid arthritis	3.18e-05	0.00164	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	3.1e-05	0.00159	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SLC25A12—rheumatoid arthritis	3.07e-05	0.00158	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	3.05e-05	0.00157	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MTHFR—rheumatoid arthritis	3e-05	0.00154	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GC—rheumatoid arthritis	2.99e-05	0.00154	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGES—rheumatoid arthritis	2.99e-05	0.00154	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PLB1—rheumatoid arthritis	2.96e-05	0.00152	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	2.89e-05	0.00149	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ENO1—rheumatoid arthritis	2.87e-05	0.00148	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PLB1—rheumatoid arthritis	2.78e-05	0.00143	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDK6—rheumatoid arthritis	2.71e-05	0.00139	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—UBE2D1—rheumatoid arthritis	2.67e-05	0.00137	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ENO1—rheumatoid arthritis	2.62e-05	0.00135	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—BIRC5—rheumatoid arthritis	2.62e-05	0.00135	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MED1—rheumatoid arthritis	2.59e-05	0.00133	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—rheumatoid arthritis	2.58e-05	0.00133	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—BIRC5—rheumatoid arthritis	2.53e-05	0.0013	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	2.53e-05	0.0013	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CAT—rheumatoid arthritis	2.47e-05	0.00127	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MED1—rheumatoid arthritis	2.44e-05	0.00125	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDK6—rheumatoid arthritis	2.42e-05	0.00125	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—rheumatoid arthritis	2.41e-05	0.00124	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—B3GNT2—rheumatoid arthritis	2.41e-05	0.00124	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ACP5—rheumatoid arthritis	2.41e-05	0.00124	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—POMC—rheumatoid arthritis	2.4e-05	0.00123	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—UBE2D1—rheumatoid arthritis	2.38e-05	0.00123	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	2.36e-05	0.00121	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BIRC5—rheumatoid arthritis	2.34e-05	0.00121	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	2.31e-05	0.00119	CbGpPWpGaD
Cytarabine—DCK—Metabolism—B3GNT2—rheumatoid arthritis	2.26e-05	0.00117	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ACP5—rheumatoid arthritis	2.26e-05	0.00117	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BIRC5—rheumatoid arthritis	2.26e-05	0.00116	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ALB—rheumatoid arthritis	2.19e-05	0.00113	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—BGN—rheumatoid arthritis	2.17e-05	0.00112	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.14e-05	0.0011	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—NOS3—rheumatoid arthritis	2.09e-05	0.00108	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CAT—rheumatoid arthritis	2.06e-05	0.00106	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	2.06e-05	0.00106	CbGpPWpGaD
Cytarabine—DCK—Metabolism—BGN—rheumatoid arthritis	2.04e-05	0.00105	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—FADS2—rheumatoid arthritis	2.01e-05	0.00103	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	2e-05	0.00103	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ALOX5—rheumatoid arthritis	2e-05	0.00103	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.97e-05	0.00101	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.92e-05	0.000988	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—rheumatoid arthritis	1.91e-05	0.000985	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CAT—rheumatoid arthritis	1.89e-05	0.000972	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ALOX5—rheumatoid arthritis	1.88e-05	0.000966	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—FADS2—rheumatoid arthritis	1.87e-05	0.000963	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.82e-05	0.000935	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—BIRC5—rheumatoid arthritis	1.8e-05	0.000928	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MTHFR—rheumatoid arthritis	1.72e-05	0.000887	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.7e-05	0.000875	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.67e-05	0.000858	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ENO1—rheumatoid arthritis	1.63e-05	0.000837	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BIRC5—rheumatoid arthritis	1.61e-05	0.000829	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MTHFR—rheumatoid arthritis	1.58e-05	0.000811	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.57e-05	0.00081	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.56e-05	0.000802	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ENO1—rheumatoid arthritis	1.53e-05	0.000787	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.47e-05	0.000755	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—POMC—rheumatoid arthritis	1.38e-05	0.000709	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.37e-05	0.000707	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PLD4—rheumatoid arthritis	1.34e-05	0.00069	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	1.33e-05	0.000685	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ACAN—rheumatoid arthritis	1.29e-05	0.000666	CbGpPWpGaD
Cytarabine—CDA—Metabolism—POMC—rheumatoid arthritis	1.26e-05	0.000649	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ALB—rheumatoid arthritis	1.26e-05	0.000647	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PLD4—rheumatoid arthritis	1.25e-05	0.000643	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC25A12—rheumatoid arthritis	1.22e-05	0.000626	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ACAN—rheumatoid arthritis	1.21e-05	0.000621	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NOS3—rheumatoid arthritis	1.2e-05	0.000618	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GC—rheumatoid arthritis	1.18e-05	0.000609	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGES—rheumatoid arthritis	1.18e-05	0.000609	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CAT—rheumatoid arthritis	1.17e-05	0.000603	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ALB—rheumatoid arthritis	1.15e-05	0.000591	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC25A12—rheumatoid arthritis	1.13e-05	0.000584	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	1.12e-05	0.000574	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GC—rheumatoid arthritis	1.1e-05	0.000568	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGES—rheumatoid arthritis	1.1e-05	0.000568	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CAT—rheumatoid arthritis	1.1e-05	0.000567	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PLB1—rheumatoid arthritis	1.1e-05	0.000566	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NOS3—rheumatoid arthritis	1.1e-05	0.000566	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—rheumatoid arthritis	1.1e-05	0.000566	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.08e-05	0.000555	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	1.04e-05	0.000535	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PLB1—rheumatoid arthritis	1.03e-05	0.000528	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—rheumatoid arthritis	1.01e-05	0.000517	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MTHFR—rheumatoid arthritis	9.78e-06	0.000503	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MED1—rheumatoid arthritis	9.65e-06	0.000497	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MTHFR—rheumatoid arthritis	9.19e-06	0.000473	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MED1—rheumatoid arthritis	8.99e-06	0.000463	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ACP5—rheumatoid arthritis	8.97e-06	0.000462	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—B3GNT2—rheumatoid arthritis	8.97e-06	0.000462	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—rheumatoid arthritis	8.64e-06	0.000445	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—B3GNT2—rheumatoid arthritis	8.36e-06	0.00043	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ACP5—rheumatoid arthritis	8.36e-06	0.00043	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—rheumatoid arthritis	8.34e-06	0.000429	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—BGN—rheumatoid arthritis	8.08e-06	0.000416	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—POMC—rheumatoid arthritis	7.82e-06	0.000402	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—BGN—rheumatoid arthritis	7.53e-06	0.000387	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALOX5—rheumatoid arthritis	7.43e-06	0.000382	CbGpPWpGaD
Cytarabine—DCK—Metabolism—POMC—rheumatoid arthritis	7.35e-06	0.000378	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ALB—rheumatoid arthritis	7.13e-06	0.000367	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALOX5—rheumatoid arthritis	6.93e-06	0.000357	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NOS3—rheumatoid arthritis	6.82e-06	0.000351	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	6.76e-06	0.000348	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ALB—rheumatoid arthritis	6.7e-06	0.000345	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NOS3—rheumatoid arthritis	6.41e-06	0.00033	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—rheumatoid arthritis	6.24e-06	0.000321	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ENO1—rheumatoid arthritis	6.06e-06	0.000312	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—rheumatoid arthritis	5.95e-06	0.000306	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—rheumatoid arthritis	5.86e-06	0.000302	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	5.73e-06	0.000295	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.67e-06	0.000292	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ENO1—rheumatoid arthritis	5.65e-06	0.000291	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.28e-06	0.000272	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	4.51e-06	0.000232	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CAT—rheumatoid arthritis	4.36e-06	0.000224	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	4.36e-06	0.000224	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	4.1e-06	0.000211	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CAT—rheumatoid arthritis	4.07e-06	0.000209	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.98e-06	0.000205	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.98e-06	0.000205	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	3.7e-06	0.000191	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTHFR—rheumatoid arthritis	3.64e-06	0.000187	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTHFR—rheumatoid arthritis	3.39e-06	0.000175	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MED1—rheumatoid arthritis	3.25e-06	0.000167	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	3.02e-06	0.000155	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	3.02e-06	0.000155	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—POMC—rheumatoid arthritis	2.91e-06	0.00015	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.72e-06	0.00014	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—POMC—rheumatoid arthritis	2.71e-06	0.00014	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALB—rheumatoid arthritis	2.65e-06	0.000137	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NOS3—rheumatoid arthritis	2.54e-06	0.000131	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.5e-06	0.000129	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALB—rheumatoid arthritis	2.47e-06	0.000127	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NOS3—rheumatoid arthritis	2.37e-06	0.000122	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—rheumatoid arthritis	2.32e-06	0.000119	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—rheumatoid arthritis	2.16e-06	0.000111	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	2.04e-06	0.000105	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.47e-06	7.55e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.23e-06	6.3e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	9.8e-07	5.04e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	8.93e-07	4.6e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	8.55e-07	4.4e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	7.82e-07	4.02e-05	CbGpPWpGaD
